UPCOMING WEBINAR
October 9, 2025, 12:00pm Eastern Time
Webinar Description:
Oligometastatic and oligoprogressive breast cancer represent clinically distinct disease states where local therapies, particularly stereotactic body radiotherapy (SBRT), may alter the natural history and delay the need for systemic escalation. This webinar will provide a comprehensive overview of the biological rationale and current clinical evidence supporting metastasis-directed therapy in these settings. International experts will highlight patient selection, integration with systemic therapy, and ongoing clinical trials, illustrated through real-world case discussions. The session is designed to equip clinicians and researchers with practical and research-focused insights to inform multidisciplinary management and future directions in the field.
Educational Objectives:
At the end of the webinar, the audience should be able to:
Identify clinical and biological considerations and current evidence regarding oligometastatic breast cancer.
Identify current evidence and future directions for oligoprogressive breast cancer.
Discuss real-world case scenarios with multi-disciplinary input.
Advances in the applications, technologies and methodologies of stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) continue to evolve rapidly and the delivery of treatment has become more complex, making it imperative that oncology professionals remain current in the state-of-the-art techniques. The Radiosurgery Society is committed to providing educational programming that creates a forum for global collaboration to improve professional practice by increasing their level of knowledge, as required to improve competency in the field of oncology.
The target audience includes radiation oncologists, surgeons, medical physicists, nurses, residents, trainees and healthcare providers in the field of SRS/SBRT, radiation oncology and medical oncology.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The Radiosurgery Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
<em>No financial commercial support was received for this educational activity.</em>
<em>No in-kind commercial support was received for this educational activity.</em>
If continuing education credits are applicable for this webinar, a certificate will be issued upon completion of course requirements, including the online evaluation, enabling you to register your credit with the appropriate licensing boards or associations. Evaluations must be completed within 45 days of live webinar.
Please contact webinars@therss.org if you have questions.